For most people, a cataract diagnosis once meant accepting blurry, faded vision as an inevitable part of aging. But at Frantz EyeCare, that story is being rewritten, one patient at a time, thanks to a ...

FDA IND clearance enables a phase 3 program evaluating TRIESENCE for postoperative ocular inflammation and pain following cataract surgery, aiming to broaden on-label use beyond current intraocular ...

When text on street signs starts to blur or night driving feels harder than it used to, choosing a certified ophthalmologist in Cape Coral becomes less of ...

Aurion Biotech today named Dr. Marjan Farid, Director of Cornea, Cataract, and Refractive Surgery and a Clinical Professor at ...

Most health insurance plans in India don’t automatically cover LASIK, but exceptions exist. Here’s how medical necessity, limits and waiting periods determine your eligibility.

Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens ...

US News evaluated freestanding ASCs only, excluding hospital-affiliated outpatient departments to avoid overlap with hospital rankings and maintain comparability across facility types. Methodology ...

One medtech analyst raises concerns that Lensar's acquisition by Alcon is in trouble due to the company's recent priority ...

NEW YORK, March 11, 2026 /PRNewswire/ -- HelpMeSee, a global nonprofit organization dedicated to eliminating preventable cataract blindness, is featured in Healthier Together, a branded content series ...

In a healthcare landscape that continues to evolve, she acknowledges that many families may value the reassurance of a ...

Alcon and Lensar terminate merger due to FTC challenges. Lensar retains a $10M deposit and focuses on Ally laser growth. More updates on March 31.

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that three scientific abstracts highlighting its commercial products VEVYE® ...